Small Cell Lung Cancer with Metastasis to the Central Nervous System in Secondary Care. Case Report
Main Article Content
Abstract
Neuroendocrine tumors represent approximately 20% of lung cancers; most are small cell lung cancer. The WHO classification system is used to classify lung tumors. In cases where there are clinical manifestations, these will depend on the location, size and perilesional edema generated by the metastases. A 78-year-old male who presented sudden right hemiplegia and bradylalia. A simple tomography of the skull was performed where hyperdense lesions were identified in two different regions, with well-defined borders and perilesional edema, for which a simple chest tomography was performed where a left lung tumor was evidenced, through bronchoscopy bronchoalveolar lavage was performed, which reported small cells. with data suggestive of small cell carcinoma with metastasis to the central nervous system. Small cell lung cancer is the most aggressive form of lung cancer. Although characterized by rapid responses to chemotherapy and sensitivity to radiation therapy, due to early resistance to treatment, the 5-year overall survival is <10%. Clinical suspicion from the second level of care allows us to focus on a more effective diagnostic protocol.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D’Amico TA, et al. Small Cell Lung Cancer, version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2021;19(12):1441–64.
II. Meijer JJ, Leonetti A, Airò G, Tiseo M, Rolfo C. Giovannetti E, et al. Small cell lung cancer: Novel treatments beyond immunotherapy. Semin Cancer Biol 2022; 8n (Pt 2):376–85.
III. Matera R, Chiang A. What is new in small cell lung cancer. Hematol Oncol Clin North Am 2023.
IV. Hatton N, Samuel R, Riaz M, Johnson C, Cheeseman SL, Snee M. A study of non small cell lung cancer (NSCLC) patients with brain metastasis: A single centre experience. Cancer Treat Res Commun 2023;34(100673):100673.
V. Zhu Y, Cui Y, Zheng X, Zhao Y, Sun G. Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment. Biochim Biophys Acta Mol Basis Dis 2022;1868(12):166557.
VI. Dingemans AMCD, Früh M, Ardizzoni A, Besse B, C. Faivre FC, et al, Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Volume 32, Issue 7, 2021
VII. Rudin, CM, Brambilla E, Finn CF. Small-cell lung cancer. Nat Rev Dis Primers 7, 3 (2021).
VIII. Carter BW, Glisson BS, Truong MI, Erasmus JJ. Small Cell Lung Carcinoma: Staging, Imaging, and Treatment Considerations, MD Radio Graphics 2014; 34:1707-1721
IX. Meerbeeck JPAV, Fennell DA, De Ruysscher DKM. Small-cell lung cancer. Lancet 2011; 378: 1741–55.